These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 21384077)

  • 1. Perioperative antiplatelet therapy: a knife-edged choice between thrombosis and bleeding still based on consensus rather than evidence.
    Peter K; Myles PS
    Thromb Haemost; 2011 May; 105(5):750-1. PubMed ID: 21384077
    [No Abstract]   [Full Text] [Related]  

  • 2. Peri-operative management of antiplatelet therapy in patients with coronary artery disease: joint position paper by members of the working group on Perioperative Haemostasis of the Society on Thrombosis and Haemostasis Research (GTH), the working group on Perioperative Coagulation of the Austrian Society for Anesthesiology, Resuscitation and Intensive Care (ÖGARI) and the Working Group Thrombosis of the European Society for Cardiology (ESC).
    Korte W; Cattaneo M; Chassot PG; Eichinger S; von Heymann C; Hofmann N; Rickli H; Spannagl M; Ziegler B; Verheugt F; Huber K
    Thromb Haemost; 2011 May; 105(5):743-9. PubMed ID: 21437351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Individualized antithrombotic therapy in high risk patients after coronary stenting. A double-edged sword between thrombosis and bleeding.
    May AE; Geisler T; Gawaz M
    Thromb Haemost; 2008 Mar; 99(3):487-93. PubMed ID: 18327396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiplatelet therapy during perioperative period: double-edged sword.
    Kozuma K
    J Cardiol; 2014 Nov; 64(5):331-3. PubMed ID: 24861910
    [No Abstract]   [Full Text] [Related]  

  • 5. Platelet function testing and risk of bleeding complications.
    Ferreiro JL; Sibbing D; Angiolillo DJ
    Thromb Haemost; 2010 Jun; 103(6):1128-35. PubMed ID: 20352168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The patient with coronary stents and antiplatelet agents: what to do and how to deal?
    Bornemann H; Prüller F; Metzler H
    Eur J Anaesthesiol; 2010 May; 27(5):406-10. PubMed ID: 20009935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiplatelet therapy in the perioperative period.
    Václavík J; Táborský M
    Eur J Intern Med; 2011 Feb; 22(1):26-31. PubMed ID: 21238889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of platelet-directed pharmacotherapy in patients with atherosclerotic coronary artery disease undergoing elective endoscopic gastrointestinal procedures.
    Becker RC; Scheiman J; Dauerman HL; Spencer F; Rao S; Sabatine M; Johnson DA; Chan F; Abraham NS; Quigley EM;
    Am J Gastroenterol; 2009 Dec; 104(12):2903-17. PubMed ID: 19935784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Possibility of a rebound phenomenon following antiplatelet therapy withdrawal: a look at the clinical and pharmacological evidence.
    Lordkipanidzé M; Diodati JG; Pharand C
    Pharmacol Ther; 2009 Aug; 123(2):178-86. PubMed ID: 19426760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significant gastrointestinal bleeding in patients at risk of coronary stent thrombosis.
    Dai X; Makaryus AN; Makaryus JN; Jauhar R
    Rev Cardiovasc Med; 2009; 10(1):14-24. PubMed ID: 19367228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Surgical procedures in patients treated with platelet function inhibitors].
    Rupprecht HJ; Blank R; Konradi D; Andreas K; Auerbach H
    Herz; 2008 Jun; 33(4):254-9. PubMed ID: 18581074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The management of antiplatelet therapy in patients with coronary stents undergoing noncardiac surgery.
    Chen TH; Matyal R
    Semin Cardiothorac Vasc Anesth; 2010 Dec; 14(4):256-73. PubMed ID: 21059610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combining antiplatelet and anticoagulant therapies.
    Holmes DR; Kereiakes DJ; Kleiman NS; Moliterno DJ; Patti G; Grines CL
    J Am Coll Cardiol; 2009 Jul; 54(2):95-109. PubMed ID: 19573725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical pharmacology of antithrombotic drugs in coronary artery disease.
    Fauler J
    Ther Adv Cardiovasc Dis; 2009 Dec; 3(6):465-78. PubMed ID: 19726525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical pharmacology: antiplatelet therapy during surgery.
    Möllmann H; Nef HM; Hamm CW
    Heart; 2010 Jun; 96(12):986-91. PubMed ID: 20538676
    [No Abstract]   [Full Text] [Related]  

  • 16. Management of anticoagulation therapy for invasive procedures.
    Gaines KK
    Urol Nurs; 2005 Oct; 25(5):379-80. PubMed ID: 16294616
    [No Abstract]   [Full Text] [Related]  

  • 17. Thrombin receptor antagonism -the potential of antiplatelet medication SCH 530348.
    Macaulay TE; Allen C; Ziada KM
    Expert Opin Pharmacother; 2010 Apr; 11(6):1015-22. PubMed ID: 20307225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiplatelet drugs: a review of their pharmacology and management in the perioperative period.
    Hall R; Mazer CD
    Anesth Analg; 2011 Feb; 112(2):292-318. PubMed ID: 21212258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is increased platelet turnover responsible for low responsiveness to different thienopyridienes? A case report of recurrent stent thromboses.
    Freynhofer MK; Bruno V; Brozovic I; Grove EL; Kristensen SD; Willheim M; Hübl W; Huber K
    Thromb Haemost; 2011 Jul; 106(1):182-4. PubMed ID: 21544319
    [No Abstract]   [Full Text] [Related]  

  • 20. Benefits and risks of clopidogrel use in patients with coronary artery disease: evidence from randomized studies and registries.
    Motovska Z; Kala P
    Clin Ther; 2008; 30 Pt 2():2191-202. PubMed ID: 19281914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.